Anthrax vaccine: a review

被引：20
|
作者：
Grabenstein, JD [1 ]
机构：
[1] USA, Med Command, Falls Church, VA 22041 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2003年 / 23卷 / 04期
关键词：
D O I：
10.1016/S0889-8561(03)00093-6
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Anthrax is a zoonotic disease, primarily of ruminants, that is caused by Bacillus anthracis. The three most common forms of anthrax are cutaneous, inhalational, and gastrointestinal. Anthrax can be a deadly disease if treatment does not begin early in the course of infection. An effective vaccine has been available in the United States since 1970, although it was not used widely until 1998. Research is underway to change the current US-licensed vaccine's route of administration to intramuscular and to reduce the number of doses in the basic series.
引用
收藏
页码：713 / +
页数：19
相关论文
共 50 条
  • [21] Absence of mycoplasma contamination in the anthrax vaccine
    Hart, MK
    Del Giudice, RA
    Korch, GW
    EMERGING INFECTIOUS DISEASES, 2002, 8 (01) : 94 - 96
  • [22] Anthrax vaccine associated with joint disorders
    Reactions Weekly, 2002, 902 (1) : 4 - 4
  • [23] Articular complaints following anthrax vaccine
    Brenner, AI
    Gale, AD
    Lyle, JM
    Moulton, LH
    Sever, JL
    Ward, BJ
    West, DJ
    ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3417 - 3417
  • [24] Anthrax recombinant antigens for vaccine development
    Ryabchevskaya, E.
    Granovskiy, D.
    Evtushenko, E.
    Ivanov, P.
    Kondakova, O.
    Nikitin, N.
    Karpova, O.
    FEBS OPEN BIO, 2022, 12 : 243 - 243
  • [25] Latex content in the anthrax vaccine absorbed
    Davenport, Julie
    Gomez, Robert
    Smith, Derek
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (09): : 3201 - 3202
  • [26] Antibodies to squalene in recipients of anthrax vaccine
    Asa, PB
    Wilson, RB
    Garry, RF
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2002, 73 (01) : 19 - 27
  • [27] Spinach makes a safer anthrax vaccine
    Sussman, HE
    DRUG DISCOVERY TODAY, 2003, 8 (10) : 428 - 430
  • [28] Appropriation and commercialization of the Pasteur anthrax vaccine
    Cassier, Maurice
    STUDIES IN HISTORY AND PHILOSOPHY OF SCIENCE PART C-STUDIES IN HISTORY AND PHILOSOPHY OF BIOLOGICAL AND BIOMEDIAL SCIENCES, 2005, 36 (04): : 722 - 742
  • [29] HHS terminates anthrax vaccine contract
    Mair, Michael
    BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE, 2007, 5 (01) : 6 - 7
  • [30] Potentiation of an anthrax DNA vaccine with electroporation
    Luxembourg, A.
    Hannaman, D.
    Nolan, E.
    Ellefsen, B.
    Nakamura, G.
    Chau, L.
    Tellez, O.
    Little, S.
    Bernard, R.
    VACCINE, 2008, 26 (40) : 5216 - 5222
12345